| Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells F Norozi, A Ahmadzadeh, S Shahrabi, T Vosoughi, N Saki Tumor Biology 37, 11679-11689, 2016 | 81 | 2016 |
| Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches AA Asnafi, Z Deris Zayeri, S Shahrabi, K Zibara, T Vosughi Journal of cellular physiology 234 (5), 5798-5806, 2019 | 42 | 2019 |
| The role of HDACs as leukemia therapy targets using HDI A Ahmadzadeh, E Khodadi, M Shahjahani, J Bertacchini, T Vosoughi, ... International journal of hematology-oncology and stem cell research 9 (4), 203, 2015 | 26 | 2015 |
| BRAF mutation in hairy cell leukemia A Ahmadzadeh, S Shahrabi, K Jaseb, F Norozi, M Shahjahani, ... Oncology reviews 8 (2), 2014 | 24 | 2014 |
| Significance of inactivated genes in leukemia: pathogenesis and prognosis N Heidari, S Abroun, J Bertacchini, T Vosoughi, F Rahim, N Saki Cell Journal (Yakhteh) 19 (Suppl 1), 9, 2017 | 20 | 2017 |
| Genetics and Epigenetics of Glioblastoma: Therapeutic Challenges. S Rasras, K Zibara, T Vosughi, Z Zayeri Clinical Cancer Investigation Journal 7 (2), 2018 | 17 | 2018 |
| CD markers variations in chronic lymphocytic leukemia: New insights into prognosis T Vosoughi, M Bagheri, M Hosseinzadeh, A Ehsanpour, N Davari, N Saki Journal of Cellular Physiology 234 (11), 19420-19439, 2019 | 13 | 2019 |
| Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis M Maleknia, S Shahrabi, M Ghanavat, T Vosoughi, N Saki Molecular biology reports 47, 4767-4778, 2020 | 9 | 2020 |
| Incidence of T315I mutation in BCR/ABL-positive CML and ALL patients F Norozi, J Mohammadi-asl, T Vosoughi, MAJ Far, AS Malehi, N Saki Frontiers in Biology 11, 404-411, 2016 | 6 | 2016 |
| Evaluation of immunophenotypic markers and clinico-hematological profile in chronic lymphocytic leukemia: implications for prognosis M Bagheri, T Vosoughi, M Hosseinzadeh, N Saki BMC Research Notes 13, 1-6, 2020 | 4 | 2020 |
| COMPARISON OF A 10 DAY TRIPLE AND A TWO-WEEK QUADRUPLE THERAPY IN ERADICATING HELICOBACTER PYLORI INFECTION IN PATIENTS REFERRED TO IMAM KHOMEINI HOSPITAL CLINICS AHWAZ, IRAN HE 3- Hashemi J, Vosoghi T Jundishapur Journal of Pharmaceutical Natural Products 3 (1), 45-52, 2008 | 4* | 2008 |
| The effect of the combined intervention of low-intensity exercise and slow stroke back massage (SSBM) on physical activity and severity of fatigue in the patients undergoing … M Fazeli, M Asadizaker, S Jahani, E Maraghi, T Vosoughi Jundishapur Journal of Chronic Disease Care 10 (2), 2021 | 3 | 2021 |
| How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in chronic myeloid leukaemia patients? N Heidari, T Vosoughi, J Mohammadi Asl, A Saki Malehi, N Saki Biomarkers 23 (3), 271-276, 2018 | 3 | 2018 |
| A comparison of the effects of every day and every other day administration of Granulocyte - colony stimulating factor (G-CSF) on the number of leukocyte, platelets … AAM Ahmad Ahmadzadeh Deylami, Mehran Hoseinzadeh, Tina Vosoghi Bali Medical Journal 6 (3), 674-678, 2017 | 2 | 2017 |
| The mechanistic role of epigenetic in multiple myeloma S Hajizamani, N Golchin, M Shahjahani, GH Tamaddon, T Vosoughi, ... Comparative Clinical Pathology 25, 1279-1288, 2016 | 2 | 2016 |
| Is Wilms’ tumor gene 1 a useful biomarker for detecting minimal residual disease in chronic myeloid leukemia (BCR-ABL1-p210-positive) patients? S Hajizamani, J Mohammadi-asl, AS Malehi, A Ahmadzadeh, T Vosoughi, ... Comparative Clinical Pathology 25, 713-720, 2016 | 2 | 2016 |
| Human leukocyte antigen-B phenotype and minimal residual disease in chronic myeloid leukemia patients treated with imatinib: Is there an association? E Hadad, A Ehsanpour, T Vosoughi, N Saki Clinical Cancer Investigation Journal 9 (2), 2020 | 1 | 2020 |
| Therapeutic effect of ferrous sulfate in diabetic patients with iron deficiency anaemia: a randomised controlled trial B Taati, R Ganji, L Moradi, T Vosoughi, A Gisouei Annals of Medicine and Surgery 86 (4), 1989-1996, 2024 | | 2024 |
| Evaluation of HLA-B* 05,* 07,* 08,* 27 and* 51 Allele Expression in Adults with Immune Thrombocytopenic Purpura NY Rad, T Vosoughi, A Ehsanpour, S Najmaldin, SMS Pezeshki Maedica 18 (1), 61, 2023 | | 2023 |
| the relationship between the incidence of pancytopenia and disease prognosis in hospitalized patients with civide-19 AP Hanieh Raji,Zahra Mehraban,Tina Vosoughi,Heshmatollah Tavakkol,Seyed ... International Journal of Health Sciences,, 48011–48019., 2022 | | 2022 |
Ahmad ahmadzadehThalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur在 ajums.ac.ir 的电子邮件经过验证
